Aire Advisors’s CVS Health CVS Stock Holding History

Aire Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,249	Closed	-$228K	–	152
2022 Q1	$228K	Buy	+2,249	New	+$236K	0.08%	131

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aire Advisors's CVS Position: Q2 2022 in Review

Aire Advisors sold out of CVS Health (CVS) in Q2 2022, closing a stake of 2,249 shares — an estimated $228K sold.

Aire Advisors first reported a position in CVS in Q1 2022 and held it in 1 quarter. The position peaked at $228K in Q1 2022. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Aire Advisors reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
Aire Advisors sold 2,249 CVS Health shares in Q2 2022, an estimated $228K.
Aire Advisors first reported a position in CVS Health in Q1 2022 and held it in 1 quarter.
Aire Advisors's CVS Health position peaked at $228K in Q1 2022.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Aire Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.